Back to Search
Start Over
714MO Datopotamab deruxtecan (Dato-DXd) in patients with endometrial (EC) or ovarian cancer (OC): Results from the phase II TROPION-PanTumor03 study.
- Source :
-
Annals of Oncology . 2024 Supplement 2, Vol. 35, pS547-S548. 2p. - Publication Year :
- 2024
- Subjects :
- *OVARIAN cancer
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 179692173
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.08.776